John Barry - Miromatrix Medical VP RD
| MIRODelisted Stock | USD 1.49 0.22 12.87% |
Insider
John Barry is VP RD of Miromatrix Medical
| Phone | 952 942 6000 |
| Web | https://www.miromatrix.com |
John Barry Latest Insider Activity
Tracking and analyzing the buying and selling activities of John Barry against Miromatrix Medical stock is an integral part of due diligence when investing in Miromatrix Medical. John Barry insider activity provides valuable insight into whether Miromatrix Medical is net buyers or sellers over its current business cycle. Note, Miromatrix Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Miromatrix Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
John Barry over six months ago Acquisition by John Barry of 4610490 shares of Prospect Capital at 4.7732 subject to Rule 16b-3 |
Miromatrix Medical Management Efficiency
The company has return on total asset (ROA) of (0.5584) % which means that it has lost $0.5584 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1354) %, meaning that it created substantial loss on money invested by shareholders. Miromatrix Medical's management efficiency ratios could be used to measure how well Miromatrix Medical manages its routine affairs as well as how well it operates its assets and liabilities.Miromatrix Medical currently holds 3.55 M in liabilities with Debt to Equity (D/E) ratio of 0.1, which may suggest the company is not taking enough advantage from borrowing. Miromatrix Medical has a current ratio of 8.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Miromatrix Medical's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Susan MS | Eliem Therapeutics | N/A | |
| Jesper Olsen | Acrivon Therapeutics, Common | N/A | |
| Seth Lewis | Molecular Partners AG | N/A | |
| Caroline Godfrey | PepGen | N/A | |
| Brian McAlister | NervGen Pharma Corp | N/A | |
| Scott Anderson | Anebulo Pharmaceuticals | N/A | |
| Wim Souverijns | Pharvaris BV | 53 | |
| Eric Devroe | Acrivon Therapeutics, Common | 45 | |
| Errol Souza | Bionomics Ltd ADR | 71 | |
| Harold DMD | NervGen Pharma Corp | N/A | |
| Michael Gait | PepGen | N/A | |
| Paul MD | AN2 Therapeutics | 54 | |
| Adam MD | NervGen Pharma Corp | N/A | |
| Alexander Zurcher | Molecular Partners AG | 49 | |
| MD FACP | AN2 Therapeutics | 76 | |
| Jennifer Cormier | PepGen | N/A | |
| David Lovejoy | Protagenic Therapeutics | N/A | |
| Maryann Cimino | Pharvaris BV | N/A | |
| Andreas EMBA | Molecular Partners AG | 58 | |
| Noel MBA | PepGen | 54 | |
| James McArthur | PepGen | 62 | |
Management Performance
| Return On Equity | -1.14 | |||
| Return On Asset | -0.56 |
Miromatrix Medical Leadership Team
Elected by the shareholders, the Miromatrix Medical's board of directors comprises two types of representatives: Miromatrix Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Miromatrix. The board's role is to monitor Miromatrix Medical's management team and ensure that shareholders' interests are well served. Miromatrix Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Miromatrix Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brian CPA, CFO Fin | ||
| Jeffrey Ross, CEO Director | ||
| James Douglas, CFO Sec | ||
| John Barry, VP RD | ||
| Tom Emig, VP Culture |
Miromatrix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Miromatrix Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.14 | |||
| Return On Asset | -0.56 | |||
| Operating Margin | (593.69) % | |||
| Current Valuation | 80.11 M | |||
| Shares Outstanding | 27.42 M | |||
| Shares Owned By Insiders | 23.95 % | |||
| Shares Owned By Institutions | 25.75 % | |||
| Number Of Shares Shorted | 11.66 K | |||
| Price To Book | 5.98 X | |||
| Price To Sales | 97.02 X |
Pair Trading with Miromatrix Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Miromatrix Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Miromatrix Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Miromatrix Stock
Moving against Miromatrix Stock
| 0.83 | HYMTF | Hyundai Motor | PairCorr |
| 0.82 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.79 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.73 | EC | Ecopetrol SA ADR | PairCorr |
| 0.69 | PFE | Pfizer Inc Aggressive Push | PairCorr |
The ability to find closely correlated positions to Miromatrix Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Miromatrix Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Miromatrix Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Miromatrix Medical to buy it.
The correlation of Miromatrix Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Miromatrix Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Miromatrix Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Miromatrix Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Miromatrix Stock
If you are still planning to invest in Miromatrix Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Miromatrix Medical's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |